4//SEC Filing
Canarick Robert 4
Accession 0001345281-21-000002
CIK 0001016504other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 6:46 PM ET
Size
5.8 KB
Accession
0001345281-21-000002
Insider Transaction Report
Form 4
Canarick Robert
Director
Transactions
- Award
Stock Option (right to buy)
2021-11-03+50,000→ 50,000 totalExp: 2031-11-03→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission (the "Issue Date").
- [F2]The option vests and becomes exercisable as follows: 25% (12,500 shares) on the Issue Date, 25% (12,500 shares) on December 31, 2021, 25% (12,500 shares) on March 31, 2022 and 25% (12,500 shares) on June 30, 2022.
Documents
Issuer
INTEGRATED BIOPHARMA INC
CIK 0001016504
Entity typeother
Related Parties
1- filerCIK 0001382218
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 6:46 PM ET
- Size
- 5.8 KB